Kloszewska I

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (5)

Title : No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease - Chiam_2015_J.Alzheimers.Dis_47_741
Author(s) : Chiam JT , Lunnon K , Voyle N , Proitsi P , Coppola G , Geschwind D , Nelson S , Johnston C , Soininen H , Kloszewska I , Mecocci P , Tsolaki M , Vellas B , Hodges A , Lovestone S , Newhouse S , Dobson RJ , Kiddle SJ , Sattlecker M
Ref : J Alzheimers Dis , 47 :741 , 2015
Abstract : Chiam_2015_J.Alzheimers.Dis_47_741
ESTHER : Chiam_2015_J.Alzheimers.Dis_47_741
PubMedSearch : Chiam_2015_J.Alzheimers.Dis_47_741
PubMedID: 26401708

Title : Plasma Abeta levels as predictors of response to rivastigmine treatment in Alzheimer's disease - Sobow_2007_Acta.Neurobiol.Exp.(Wars)_67_131
Author(s) : Sobow T , Flirski M , Liberski P , Kloszewska I
Ref : Acta Neurobiol Exp (Wars) , 67 :131 , 2007
Abstract : Sobow_2007_Acta.Neurobiol.Exp.(Wars)_67_131
ESTHER : Sobow_2007_Acta.Neurobiol.Exp.(Wars)_67_131
PubMedSearch : Sobow_2007_Acta.Neurobiol.Exp.(Wars)_67_131
PubMedID: 17691220

Title : Cholinesterase inhibitors in mild cognitive impairment: a meta-analysis of randomized controlled trials - Sobow_2007_Neurol.Neurochir.Pol_41_13
Author(s) : Sobow T , Kloszewska I
Ref : Neurol Neurochir Pol , 41 :13 , 2007
Abstract : Sobow_2007_Neurol.Neurochir.Pol_41_13
ESTHER : Sobow_2007_Neurol.Neurochir.Pol_41_13
PubMedSearch : Sobow_2007_Neurol.Neurochir.Pol_41_13
PubMedID: 17330176

Title : Short-term treatment with rivastigmine and plasma levels of Abeta peptides in Alzheimer's disease - Sobow_2005_Folia.Neuropathol_43_340
Author(s) : Sobow T , Kloszewska I
Ref : Folia Neuropathol , 43 :340 , 2005
Abstract : Sobow_2005_Folia.Neuropathol_43_340
ESTHER : Sobow_2005_Folia.Neuropathol_43_340
PubMedSearch : Sobow_2005_Folia.Neuropathol_43_340
PubMedID: 16416397

Title : [The costs of Alzheimer's disease treatment: the rationale of acetylcholinesterase inhibitors use?] - Sobow_1999_Psychiatr.Pol_33_761
Author(s) : Sobow TM , Kloszewska I
Ref : Psychiatr Pol , 33 :761 , 1999
Abstract : Sobow_1999_Psychiatr.Pol_33_761
ESTHER : Sobow_1999_Psychiatr.Pol_33_761
PubMedSearch : Sobow_1999_Psychiatr.Pol_33_761
PubMedID: 10761441